Adenoviridae Infections - 138 Studies Found
| Recruiting |
: Safety Study of Adenovirus Hepatocyte Growth Factor to Treat Ischemic Heart Disease : Ischemic Heart Disease : 2013-08-15 : Drug: Ad-HGF 5×10(9)pfu adenovirus hepatocyte growth factor was delivered by transendocardial injec |
| Terminated |
: Efficacy Study of Recombinant Adenovirus for Non Muscle Invasive Bladder Cancer :
|
| Recruiting |
: Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects :
|
| Completed |
: Study of Nitazoxanide Suspension in the Treatment of Diarrhea Caused by Enteric Viruses in Children :
|
| Completed |
: Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1) :
: 2006-03-24 : Biological: adenoviral vector encoding rat Her-2/neu Group 1 1 x 10'7 pfu (2.5 X 10'6 pfu per injection |
| Completed |
: Adenovirus CCL-21 Transduced MART-1/gp100/Tyrosinase/NY-ESO-1 Peptide-Pulsed Dendritic Cells Matured : Melanoma (Skin) : 2008-11-25 : Biological: Autologous dendritic cell-adenovirus CCL21 vaccine Intradermal injections of adenovirus-CCL- |
| Active, not recruiting |
: Phase II Study of Adenovirus/PSA Vaccine in Men With Hormone - Refractory Prostate Cancer : Hormone Refractory Prostate Cancer : 2007-12-20 : Biological: ADENOVIRUS/PSA VACCINE 1x10E8 pfu in Gelfoam subcutaneously on days 0, 30, 60 |
| Active, not recruiting |
: Phase II Study of Adenovirus/PSA Vaccine in Men With Recurrent Prostate Cancer After Local Therapy APP21 : Recurrent Prostate Cancer : 2007-12-20 : Biological: Adenovirus/PSA Vaccine 1x10E8pfu in Gelfoam subcutaneously on day 0, 30, 60 |
| Withdrawn |
: GOAT; Phase I Open Label Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Advanced Cancers :
: 2011-09-15 : Biological: CGTG-102 VP=virus particle |